Deese J, Masson L, Miller W, Cohen M, Morrison C, Agot K, Ahmed K, Crucitti T, Abdellati S, and Van Damme L. HIV Research for Prevention, Chicago, Illinois, October 2016. Poster presentation on “Local cytokine elevation Is associated with HIV acquisition among African women”.

Masson L, Barnabas S, Deese J, Arnold KB, Little F, Dabee S, Mlisana K, Lewis DA, Van Damme L, Crucitti T, Abdellati S, Mkhize N, Gamieldien H, Ngcapu S, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, and Passmore JS. World STI and HIV Congress, Brisbane, Australia, September 2015. Oral presentation on “Inflammatory cytokine biomarkers to identify women with asymptomatic STIs and BV who are at high risk of HIV infection”.

Deese J, Masson L, Miller W, Cohen M, Morrison C, Wang M, Ahmed K, Agot K, Crucitti T, Abdellati S, and Van Damme L. International AIDS Society Conference, Vancouver, Canada, July 2015. Poster presentation on “Injectable progestin‐only contraception is associated with increased levels of pro‐inflammatory cytokines in the female genital tract”.

Deese J. Mucosal Immunology and HIV Prevention Workshop, Durban, South Africa, 2013. Oral presentation on “The association between selected biomarkers, HIV and possible covariates of HIV risk: A cross‐ sectional analysis of participant genital specimens in the FEM‐PrEP trial”.

Deese J, Ahmed K, Agot K, Rountree W, Mullins S, Johnson L, Lanham M, Wong C, Corneli A and Van Damme L. Microbicides Conference, Philadelphia, Pennsylvania, May 2010. Poster presentation on “Self‐reported adherence to daily oral Truvada in the FEM‐PrEP trial”.

Deese J, Ahmed K, Agot K, Lie C, Kiernan H, and Van Damme L. Microbicides Conference, Philadelphia, Pennsylvania, May 2010. Oral presentation on “Unmet family planning needs among HIV‐positive participants screened for FEM‐PrEP”.

Van Damme L, Govinden R, Mirembe F, Guedou F, Solomon S, Becker ML, Pradeep B, Alary M, Nakabito C, Ramjee G, Murphy S, Deese J, Crucitti T, and Taylor D. International AIDS Society, Sydney, Australia, July 2007. Oral presentation on “Phase III trial of 6% cellulose sulfate (CS) gel for the prevention of HIV transmission”.

Deese J. Microbicides Conference, Cape Town, South Africa, April 2006. Oral presentation on “Informed consent in a phase III trial of cellulose sulfate: Process, experiences & challenges”.

Caraway J, Van Damme L, and Acevedo N. Microbicides Conference, Cape Town, South Africa, April 2006. Poster presentation on “Organization and implementation of a multi‐country randomized controlled trial”.